Medical/Pharmaceuticals

Representatives From Over 100 Countries Took Part in the "Open Innovations" Forum in Moscow

MOSCOW, Oct. 24, 2019 /PRNewswire/ -- The VIII Moscow International Forum of Innovative Development "Open Innovations" took place inMoscow - the main annual event inRussia in the field of technological entrepreneurship. ...

2019-10-24 01:23 209

World Federation of Neurology Joins Forces with the World Health Organization, Announcing "Groundbreaking" Reclassification of Stroke as a Disorder of the Brain; Launches Nine-Country Survey, Leading to Roadmap for Improved Neurological Care

LONDON, Oct. 24, 2019 /PRNewswire/ -- The World Federation of Neurology (WFN) is joining forces with the World Health Organization (WHO) to create global standards of neurological care. TheXXIV World Congress of Neurology (WCN 2019) taking placeOct. 27-31 in Dubai, UAE, will emphasize the importa...

2019-10-24 00:42 343

Mundipharma Thailand Recognised as "Best Companies to Work for in Asia" Award

BANGKOK, Oct. 23, 2019 /PRNewswire/ -- Mundipharma was named one of the "Best Companies to Work for inAsia" in Thailand by HR Asia -- the premier publication on human resource professionals in theAsia Pacific. This is the first time Mundipharma Thailand has won the award in the country.

2019-10-23 13:32 238

Osteopore(R) highly commended for its innovative healthcare product at TCT Awards

PERTH, Australia and SYDNEY, Oct. 23, 2019 /PRNewswire/ -- Osteopore, a medical device company that designs and manufactures regenerative implants made via 3D printing, has been highly commended at the prestigious TCT Awards where industry leaders celebrate innovators, technologies, and collabora...

2019-10-23 09:00 260

Chugai Renews License to EpiVax's ISPRI In Silico Toolkit for Immunogenicity Assessment

PROVIDENCE, Rhode Island, Oct. 23, 2019 /PRNewswire/ -- Announced today, Chugai Pharmaceutical Co., Ltd. ("Chugai"), a member of the Roche Group, will extend the company's licensed access to theImmunogenicity Screening and Protein Reengineering Interface (ISPRI) toolkit developed by EpiVax, Inc. ...

2019-10-23 04:10 250

TissueCypher® Further Validated to Accurately Risk Stratify Barrett's Esophagus Patients With Non-Dysplastic or Low-Grade Dysplasia Diagnoses: Findings Shared at Two Major GI Conferences

Data presented at ACG, UEGW illustrates the fourth independent validation of TissueCypher performance for risk stratifying non-dysplasticBarrett's esophagus (NDBE) patients; expands indication for testing low-grade dysplasia (LGD) PITTSBURGH, Oct. 23, 2019 /PRNewswire/ -- Cernostics, developer of...

2019-10-23 01:59 273

Western Australia aims to reduce amputation rates and improve patient care with state-wide Silhouette(R) implementation

CHRISTCHURCH, New Zealand, Oct. 22, 2019 /PRNewswire/ -- ARANZ Medical's Silhouette system is being deployed inWestern Australia to improve the care provided for diabetes patients across the entire state. Aboriginal Health Workers and Diabete...

2019-10-22 22:50 297

BioGX Receives CE-IVD Mark For Enhanced Flu Assay

AMSTERDAM, Oct. 22, 2019 /PRNewswire/ -- BioGX B.V., the European subsidiary of Birmingham, Alabama based BioGX, announced it has received CE-IVD marking for its new Flu A, Flu B, RSV A/B automated test. The new test significantly enhances the strain coverage and detection sensitivity and offers ...

2019-10-22 20:07 235

Zuellig Pharma enters into strategic partnership with Eli Lilly and Company in Malaysia and Thailand

SINGAPORE, Oct. 22, 2019 /PRNewswire/ -- Zuellig Pharma, a leading healthcare service provider inAsia, is pleased to announce two new strategic partnerships with Eli Lilly and Company (Lilly) to market, sell and distribute the healthcare manufacturer's existing and new products inMalaysia and Tha...

2019-10-22 17:10 613

HCmed introduces Pulmogine in the 2019 ERS Congress

TAIPEI, Oct. 22, 2019 /PRNewswire/ -- HCmed Innovations Co., Inc., a drug-device combination company focused on inhalation therapy, presented its latest brand, Pulmogine, in the 2019 ERS International Congress. Pulmogine, a mesh nebulizer supported by a customization platform, is able to nebulize...

2019-10-22 16:34 338

Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health

SHANGHAI, Oct. 22, 2019 /PRNewswire/ -- The implementation of the "Healthy China 2030" Planning Outline has ushered in rapid development of China's big health industry, with the industry scale expected to reachRMB8.78 trillion in 2019 andRMB14.09 trillion in 2023, calculated as per the about 12.5...

2019-10-22 12:11 277

Natural Extracts Innovated, Transformed and Diversely Laid Out to Embrace the Blue Ocean Market of Big Health

SHANGHAI, Oct. 22, 2019 /PRNewswire/ -- The implementation of the "Healthy China 2030" Planning Outline has ushered in rapid development of China's big health industry, with the industry scale expected to reachRMB8.78 trillion in 2019 andRMB14.09 trillion in 2023, calculated as per the about 12.5...

2019-10-22 12:08 228

Apollo Hospitals' Unique Initiative to Provide Best Treatment Plan for Cancer Patients

HYDERABAD, India, Oct. 22, 2019 /PRNewswire/ -- Cancer is the second leading cause of death globally and was responsible for over 9.6 million deaths in 2018 alone. The global burden of cancer has risen to 18.1 million new cases and cancer is having a major impact on society across the globe. Acc...

2019-10-22 09:30 260

Drug Delivery Devices Offering Enhanced Connectivity to Find Higher Uptake Among Hospitals

Vendors that provide services instead of just being a supplier of devices to enjoy greater growth opportunities, finds Frost & Sullivan SANTA CLARA, Calif., Oct. 22, 2019 /PRNewswire/ -- The rise of targeted therapy and drug compounds is prompting the development of noveldrug delivery approaches...

2019-10-22 00:23 274

Face Up To Rosacea: Galderma Launches Online Support to Empower and Equip Rosacea Sufferers to Discuss the True Burden of Their Disease With a Dermatologist

New 'Face up to rosacea' campaign comprising online content and a downloadable, personalized patient appointment guide, equips people living with the distressing skin disease to seek expert support to help break the cycle of rosacea and aim for long-term treatment success    LAUSANNE, Switzerlan...

2019-10-21 17:24 291

GN Corporation and Edogawa Evolutionary Laboratory of Science Cosponsor International Academic Conference, NCRM NICHE 2019, on October 15, 2019

KOFU, Japan and TOKYO, Oct. 21, 2019 /PRNewswire/ -- GN Corporation Co., Ltd., a Japanese firm involved in research and development of technology in regenerative medicine, and Edogawa Evolutionary Laboratory of Science(EELS), a unit ofTokyo's Edogawa Hospital, cosponsored NCRM NICHE 2019 (www.ncr...

2019-10-21 14:00 212

Mundipharma Wins "Best Companies to Work for in Asia" Award in Singapore for Third Time Running

SINGAPORE, Oct. 21, 2019 /PRNewswire/ -- Healthcare industry leader Mundipharma has been awarded the title of "Best Companies to Work for inAsia" in Singapore by HR Asia for the third time running, in the pharmaceuticals category. Mundipharma...

2019-10-21 11:49 329

Cell Signaling Technology and Cell Press Launch Cell Mentor in China

DANVERS, Massachusetts and BEIJING, Oct. 21, 2019 /PRNewswire/ -- Cell Signaling Technology (CST), a leading provider of antibodies, kits, and services, andCell Press, a leading publisher of over 40 primary research and review journals, today announced thatCell Mentor™, an educational resource fo...

2019-10-21 09:39 244

Putting Prevention First, ORENDA Initiates Health Promotion Inspired by Traditional Chinese Culture

BEIJING, Oct. 21, 2019 /PRNewswire/ -- On October 18, 2019, the First International Conference on Primary Care Medicine and Health Promotion, including the Fourth BO-AI International Symposium, kicked off inBeijing. The conference focused on the development ofChina's primary healthcare system and...

2019-10-21 09:05 275

Innovent Biologics Announces Positive Updated Result from the Incyte-sponsored Phase II Trial of Pemigatinib in Patients with Previously Treated, Advanced Cholangiocarcinoma

SUZHOU, China, Oct. 21, 2019 /PRNewswire/ --  Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today ...

2019-10-21 08:00 341
12345 ... 350